|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q56379791
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010844.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q56379791
|
|
024
|
|
|
‡a
0000-0001-8987-4596
‡2
orcid
|
|
024
|
|
|
‡a
56601175600
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q56379791
|
|
100
|
0 |
|
‡a
Silvia De Rosa
‡c
researcher
‡9
en
|
|
375
|
|
|
‡a
2
‡2
iso5218
|
|
400
|
0 |
|
‡a
Silvia De Rosa
‡c
wetenschapper
‡9
nl
|
|
400
|
0 |
|
‡a
Silvia De Rosa
‡c
investigadora
‡9
ast
|
|
400
|
0 |
|
‡a
Silvia De Rosa
‡c
ricercatrice
‡9
it
|
|
400
|
0 |
|
‡a
Silvia De Rosa
‡c
investigadora
‡9
es
|
|
670
|
|
|
‡a
Author's ACUsmart Continuous Renal Replacement Therapy Platform: Multicenter Pilot Study for Technical and Clinical Assessment (A.M.P. Study)
|
|
670
|
|
|
‡a
Author's [Acute Kidney Injury, Type - 3 cardiorenal syndrome, Biomarkers, Renal Replacement Therapy]
|
|
670
|
|
|
‡a
Author's Acute renal replacement therapy in patients with major extremity injuries.
|
|
670
|
|
|
‡a
Author's Airway management with fastrach laryngeal mask versus spritztube: a prospective randomised manikin-based study.
|
|
670
|
|
|
‡a
Author's Albumin Loss and Citrate Load in Pre-Dilution High Cut-Off-CVVHDF with Regional Citrate
|
|
670
|
|
|
‡a
Author's Albumin Loss and Citrate Load in Pre-Dilution High Cut-Off-CVVHDF with Regional Citrate (18 mmol/L) and High Cut-Off CVVHD with Systemic Heparin: An in vitro Study
|
|
670
|
|
|
‡a
Author's [Cardio-Pulmonary-Renal interactions].
|
|
670
|
|
|
‡a
Author's Creatinine-based definitions: from baseline creatinine to serum creatinine adjustment in intensive care
|
|
670
|
|
|
‡a
Author's Development of the New Kibou® Equipment for Continuous Renal Replacement Therapy from Scratch to the Final Configuration
|
|
670
|
|
|
‡a
Author's Effects of positive end expiratory pressure (PEEP) on intracranial and cerebral perfusion pressure in pediatric neurosurgical patients.
|
|
670
|
|
|
‡a
Author's ESICM LIVES 2016: part three: Milan, Italy. 1–5 October 2016
|
|
670
|
|
|
‡a
Author's ESICM LIVES 2016: part two: Milan, Italy. 1–5 October 2016
|
|
670
|
|
|
‡a
Author's [Guidelines for the prevention, diagnosis and treatment of acute kidney injury syndromes: Italian version of KDIGO, integrated with new evidence and international commentaries]
|
|
670
|
|
|
‡a
Author's Hypothermia and kidney: a focus on ischaemia-reperfusion injury.
|
|
670
|
|
|
‡a
Author's Impact of hyperhydration on the mortality risk in critically ill patients admitted in intensive care units: comparison between bioelectrical impedance vector analysis and cumulative fluid balance recording
|
|
670
|
|
|
‡a
Author's Impact of positive end expiratory pressure on cerebral hemodynamic in paediatric patients with post-traumatic brain swelling treated by surgical decompression.
|
|
670
|
|
|
‡a
Author's Intra-Parenchymal Renal Resistive Index Variation (IRRIV) Describes Renal Functional Reserve (RFR): Pilot Study in Healthy Volunteers
|
|
670
|
|
|
‡a
Author's Kinetics of Linezolid in Continuous Renal Replacement Therapy: An In Vitro Study.
|
|
670
|
|
|
‡a
Author's Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness.
|
|
670
|
|
|
‡a
Author's Markers of cardiogenic shock predict persistent acute kidney injury after out of hospital cardiac arrest
|
|
670
|
|
|
‡a
Author's Nomenclature for renal replacement therapy and blood purification techniques in critically ill patients: practical applications
|
|
670
|
|
|
‡a
Author's oXirisNet Registry: A Prospective, National Registry on the oXiris Membrane
|
|
670
|
|
|
‡a
Author's Patient Selection and Timing of Continuous Renal Replacement Therapy
|
|
670
|
|
|
‡a
Author's Pharmacokinetic Analysis of Antibiotic Adsorption
|
|
670
|
|
|
‡a
Author's Pharmacokinetic Analysis of Antibiotic Adsorption (Vancomycin and Teicoplanin) by the Lixelle Extracorporeal Unit
|
|
670
|
|
|
‡a
Author's Polymyxin B hemoperfusion in COVID-19 Patients with endotoxic shock: Case Series from EUPHAS II registry
|
|
670
|
|
|
‡a
Author's Precision Continuous Renal Replacement Therapy and Solute Control
|
|
670
|
|
|
‡a
Author's Preoperative Renal Functional Reserve Predicts Risk of Acute Kidney Injury After Cardiac Surgery
|
|
670
|
|
|
‡a
Author's Prospective, randomized, multicenter, controlled trial (TRIATHRON 1) on a new antithrombogenic hydrophilic dialysis membrane.
|
|
670
|
|
|
‡a
Author's Standard of care, controversies and innovations in the medical treatment of Severe Traumatic Brain Injury (STBI).
|
|
670
|
|
|
‡a
Author's The golden hour of polymyxin B hemoperfusion in endotoxic shock: The basis for sequential extracorporeal therapy in sepsis
|
|
670
|
|
|
‡a
Author's The Pathophysiological Hypothesis of Kidney Damage during Intra-Abdominal Hypertension
|
|
670
|
|
|
‡a
Author's Tidal volume challenge to predict fluid responsiveness in the operating room: An observational study
|
|
909
|
|
|
‡a
(scopus) 56601175600
‡9
1
|
|
909
|
|
|
‡a
(orcid) 0000000189874596
‡9
1
|
|
912
|
|
|
‡a
esicmlives2016part2milanitaly15october
‡A
ESICM LIVES 2016: part two: Milan, Italy. 1–5 October 2016
‡9
1
|
|
912
|
|
|
‡a
esicmlives2016part3milanitaly15october
‡A
ESICM LIVES 2016: part three: Milan, Italy. 1–5 October 2016
‡9
1
|
|
919
|
|
|
‡a
patientselectionandtimingofcontinuousrenalreplacementtherapy
‡A
Patient Selection and Timing of Continuous Renal Replacement Therapy
‡9
1
|
|
919
|
|
|
‡a
oxirisnetregistryaprospectivenationalregistryontheoxirismembrane
‡A
oXirisNet Registry: A Prospective, National Registry on the oXiris Membrane
‡9
1
|
|
919
|
|
|
‡a
nomenclatureforrenalreplacementtherapyandbloodpurificationtechniquesincriticallyillpatientspracticalapplications
‡A
Nomenclature for renal replacement therapy and blood purification techniques in critically ill patients: practical applications
‡9
1
|
|
919
|
|
|
‡a
markersofcardiogenicshockpredictpersistentacutekidneyinjuryafteroutofhospitalcardiacarrest
‡A
Markers of cardiogenic shock predict persistent acute kidney injury after out of hospital cardiac arrest
‡9
1
|
|
919
|
|
|
‡a
hypothermiaandkidneyafocusonischaemiareperfusioninjury
‡A
Hypothermia and kidney: a focus on ischaemia-reperfusion injury.
‡9
1
|
|
919
|
|
|
‡a
guidelinesforthepreventiondiagnosisandtreatmentofacutekidneyinjurysyndromesitalianversionofkdigointegratedwithnewevidenceandinternationalcommentaries
‡A
[Guidelines for the prevention, diagnosis and treatment of acute kidney injury syndromes: Italian version of KDIGO, integrated with new evidence and international commentaries]
‡9
1
|
|
919
|
|
|
‡a
albuminlossandcitrateloadinpredilutionhighcutoffcvvhdfwithregionalcitrate
‡A
Albumin Loss and Citrate Load in Pre-Dilution High Cut-Off-CVVHDF with Regional Citrate
‡9
1
|
|
919
|
|
|
‡a
pharmacokineticanalysisofantibioticadsorptionvancomycinandteicoplaninbythelixelleextracorporealunit
‡A
Pharmacokinetic Analysis of Antibiotic Adsorption (Vancomycin and Teicoplanin) by the Lixelle Extracorporeal Unit
‡9
1
|
|
919
|
|
|
‡a
standardofcarecontroversiesandinnovationsinthemedicaltreatmentofseveretraumaticbraininjurystbi
‡A
Standard of care, controversies and innovations in the medical treatment of Severe Traumatic Brain Injury (STBI).
‡9
1
|
|
919
|
|
|
‡a
pathophysiologicalhypothesisofkidneydamageduringintraabdominalhypertension
‡A
The Pathophysiological Hypothesis of Kidney Damage during Intra-Abdominal Hypertension
‡9
1
|
|
919
|
|
|
‡a
prospectiverandomizedmulticentercontrolledtrialtriathron1onanewantithrombogenichydrophilicdialysismembrane
‡A
Prospective, randomized, multicenter, controlled trial (TRIATHRON 1) on a new antithrombogenic hydrophilic dialysis membrane.
‡9
1
|
|
919
|
|
|
‡a
pharmacokineticanalysisofantibioticadsorption
‡A
Pharmacokinetic Analysis of Antibiotic Adsorption
‡9
1
|
|
919
|
|
|
‡a
polymyxinbhemoperfusionincovid19patientswithendotoxicshockcaseseriesfromeuphas2registry
‡A
Polymyxin B hemoperfusion in COVID-19 Patients with endotoxic shock: Case Series from EUPHAS II registry
‡9
1
|
|
919
|
|
|
‡a
goldenhourofpolymyxinbhemoperfusioninendotoxicshockthebasisforsequentialextracorporealtherapyinsepsis
‡A
The golden hour of polymyxin B hemoperfusion in endotoxic shock: The basis for sequential extracorporeal therapy in sepsis
‡9
1
|
|
919
|
|
|
‡a
albuminlossandcitrateloadinpredilutionhighcutoffcvvhdfwithregionalcitrate18mmol50andhighcutoffcvvhdwithsystemicheparinaninvitrostudy
‡A
Albumin Loss and Citrate Load in Pre-Dilution High Cut-Off-CVVHDF with Regional Citrate (18 mmol/L) and High Cut-Off CVVHD with Systemic Heparin: An in vitro Study
‡9
1
|
|
919
|
|
|
‡a
impactofpositiveendexpiratorypressureoncerebralhemodynamicinpaediatricpatientswithposttraumaticbrainswellingtreatedbysurgicaldecompression
‡A
Impact of positive end expiratory pressure on cerebral hemodynamic in paediatric patients with post-traumatic brain swelling treated by surgical decompression.
‡9
1
|
|
919
|
|
|
‡a
kineticsoflinezolidincontinuousrenalreplacementtherapyaninvitrostudy
‡A
Kinetics of Linezolid in Continuous Renal Replacement Therapy: An In Vitro Study.
‡9
1
|
|
919
|
|
|
‡a
impactofhyperhydrationonthemortalityriskincriticallyillpatientsadmittedinintensivecareunitscomparisonbetweenbioelectricalimpedancevectoranalysisandcumulativefluidbalancerecording
‡A
Impact of hyperhydration on the mortality risk in critically ill patients admitted in intensive care units: comparison between bioelectrical impedance vector analysis and cumulative fluid balance recording
‡9
1
|
|
919
|
|
|
‡a
effectsofpositiveendexpiratorypressurepeeponintracranialandcerebralperfusionpressureinpediatricneurosurgicalpatients
‡A
Effects of positive end expiratory pressure (PEEP) on intracranial and cerebral perfusion pressure in pediatric neurosurgical patients.
‡9
1
|
|
919
|
|
|
‡a
intraparenchymalrenalresistiveindexvariationirrivdescribesrenalfunctionalreserverfrpilotstudyinhealthyvolunteers
‡A
Intra-Parenchymal Renal Resistive Index Variation (IRRIV) Describes Renal Functional Reserve (RFR): Pilot Study in Healthy Volunteers
‡9
1
|
|
919
|
|
|
‡a
managementofchronickidneydiseasepatientsintheintensivecareunitmixingacuteandchronicillness
‡A
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness.
‡9
1
|
|
919
|
|
|
‡a
creatininebaseddefinitionsfrombaselinecreatininetoserumcreatinineadjustmentinintensivecare
‡A
Creatinine-based definitions: from baseline creatinine to serum creatinine adjustment in intensive care
‡9
1
|
|
919
|
|
|
‡a
developmentofthenewkibouequipmentforcontinuousrenalreplacementtherapyfromscratchtothefinalconfiguration
‡A
Development of the New Kibou® Equipment for Continuous Renal Replacement Therapy from Scratch to the Final Configuration
‡9
1
|
|
919
|
|
|
‡a
tidalvolumechallengetopredictfluidresponsivenessintheoperatingroomanobservationalstudy
‡A
Tidal volume challenge to predict fluid responsiveness in the operating room: An observational study
‡9
1
|
|
919
|
|
|
‡a
airwaymanagementwithfastrachlaryngealmaskversusspritztubeaprospectiverandomisedmanikinbasedstudy
‡A
Airway management with fastrach laryngeal mask versus spritztube: a prospective randomised manikin-based study.
‡9
1
|
|
919
|
|
|
‡a
precisioncontinuousrenalreplacementtherapyandsolutecontrol
‡A
Precision Continuous Renal Replacement Therapy and Solute Control
‡9
1
|
|
919
|
|
|
‡a
acutekidneyinjurytype3cardiorenalsyndromebiomarkersrenalreplacementtherapy
‡A
[Acute Kidney Injury, Type - 3 cardiorenal syndrome, Biomarkers, Renal Replacement Therapy]
‡9
1
|
|
919
|
|
|
‡a
cardiopulmonaryrenalinteractions
‡A
[Cardio-Pulmonary-Renal interactions].
‡9
1
|
|
919
|
|
|
‡a
acusmartcontinuousrenalreplacementtherapyplatformmulticenterpilotstudyfortechnicalandclinicalassessmenta1000pstudy
‡A
ACUsmart Continuous Renal Replacement Therapy Platform: Multicenter Pilot Study for Technical and Clinical Assessment (A.M.P. Study)
‡9
1
|
|
919
|
|
|
‡a
preoperativerenalfunctionalreservepredictsriskofacutekidneyinjuryaftercardiacsurgery
‡A
Preoperative Renal Functional Reserve Predicts Risk of Acute Kidney Injury After Cardiac Surgery
‡9
1
|
|
919
|
|
|
‡a
acuterenalreplacementtherapyinpatientswithmajorextremityinjuries
‡A
Acute renal replacement therapy in patients with major extremity injuries.
‡9
1
|
|
943
|
|
|
‡a
201x
‡A
2016
‡9
2
|
|
946
|
|
|
‡a
a
‡9
1
|
|
996
|
|
|
‡2
SUDOC|167628291
|
|
996
|
|
|
‡2
ISNI|0000000403168298
|
|
996
|
|
|
‡2
DNB|140816305
|
|
996
|
|
|
‡2
ISNI|0000000493607214
|
|
996
|
|
|
‡2
NTA|235193712
|
|
996
|
|
|
‡2
BLBNB|000367996
|
|
996
|
|
|
‡2
LC|no2010022315
|
|
996
|
|
|
‡2
BLBNB|000536775
|
|
996
|
|
|
‡2
ISNI|000000049562427X
|
|
996
|
|
|
‡2
ISNI|0000000070981714
|
|
996
|
|
|
‡2
PTBNP|1907006
|
|
996
|
|
|
‡2
PLWABN|9813175747605606
|
|
996
|
|
|
‡2
PTBNP|1871096
|
|
996
|
|
|
‡2
LC|n 2018221906
|
|
996
|
|
|
‡2
PTBNP|1014419
|
|
996
|
|
|
‡2
BNF|17924681
|
|
996
|
|
|
‡2
ICCU|CFIV272561
|
|
996
|
|
|
‡2
ISNI|0000000068777482
|
|
996
|
|
|
‡2
DNB|1225703522
|
|
996
|
|
|
‡2
LC|no2018158745
|
|
996
|
|
|
‡2
DNB|103817578X
|
|
996
|
|
|
‡2
BNE|XX6528334
|
|
996
|
|
|
‡2
SUDOC|250933934
|
|
996
|
|
|
‡2
PTBNP|117965
|
|
996
|
|
|
‡2
SUDOC|194105555
|
|
996
|
|
|
‡2
LC|no2013046926
|
|
996
|
|
|
‡2
LC|nr2004007691
|
|
996
|
|
|
‡2
JPG|500079742
|
|
996
|
|
|
‡2
ISNI|0000000080125823
|
|
996
|
|
|
‡2
BNF|16907133
|
|
996
|
|
|
‡2
LC|no2004097541
|
|
996
|
|
|
‡2
PTBNP|1432638
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
